Table 1. Clinical cohort statistical characteristics of MM status, QMG scores and MG-ADL scores.
| N = 115 | Mean | SD | Range |
|---|---|---|---|
| Age | 34.74 years | 12.59 | 18–63 |
| Women | 80 (70%) | ||
| Race/Ethnicity | |||
| Asian = 5 (4%) Black/African American = 10 (9%) White, not Hispanic origin = 58 (50%) Hispanic 34 (30%) Other (Mixed/Native American Alaskan) = 8 (7%) |
|||
| Disease Duration | 1.44 years | 1.04 | 0.02–4.41 |
| Prednisone at baseline | 47.87 | 34.91 | 0–120 |
| On Prednisone at entry | 89 (77%) | ||
| Thymectomy | 61 (53%) | ||
| MMS at 6 months | 51 | ||
| QMG at baseline | 11.8 | 5.1 | 1–24 |
| QMG at 6 months | 7.3 | 5.0 | 0–23 |
| ADL at baseline | 5.2 | 3.3 | 0–13 |
| ADL at 6 months | 2.6 | 2.9 | 0–12 |